Related Experiment Videos

Selective changes in DNA binding activity of transcription factors in UM-X7.1 cardiomyopathic hamsters

R Ambra1, P Di Nardo, C Fantini

  • 1Free Radicals Research Group, National Institute for Food and Nutrition Research, via Ardeatina 546, 00178, Rome, Italy. ambra@inran.it

Life Sciences
|September 17, 2002
PubMed

Insights

Hamster cardiomyopathy involves delta-sarcoglycan loss, impacting heart function. This study reveals altered transcription factor activity, specifically NF-AT3 and CREB, offering new insights into hereditary cardiomyopathy mechanisms.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • UM-X7.1 hamsters (CH) serve as a model for human cardiomyopathy.
  • CH exhibit delta-sarcoglycan loss, leading to myocardium remodeling and reduced heart function.
  • Molecular mechanisms of CH pathology, despite known redox and calcium imbalances, remain largely unknown.

Purpose of the Study:

  • Investigate molecular mechanisms underlying hereditary cardiomyopathy in CH.
  • Analyze the role of transcription factors in CH pathogenesis.
  • Identify novel regulatory pathways in cardiac dysfunction.

Main Methods:

  • Compared DNA binding activity of transcription factors in CH vs. normal hamster ventricles.
  • Utilized Western blot to confirm protein levels.
  • Focused on redox-related (NF-kappaB, Sp1, AP-1, AP-2) and calcium-dependent (NF-AT3, CREB) factors.

Main Results:

  • No significant difference in DNA binding activity of redox-related transcription factors.
  • Increased DNA binding activity of NF-AT3 in CH ventricles.
  • Decreased DNA binding activity and levels of CREB in CH ventricles, suggesting novel regulation.

Conclusions:

  • Altered transcription factor activity, particularly NF-AT3 and CREB, contributes to CH pathogenesis.
  • Findings provide insights into the molecular mechanisms of hamster hereditary cardiomyopathy.
  • Results align with studies on related transgenic mouse models.

Related Concept Videos